Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Placebo Effect

The Placebo Effect

The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Blind Procedures

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...

Blinding

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A vision for an academic health science centre: A survey of research engagement and barriers.

PloS one·2026

Same author

Interventions to improve adherence to clinical practice guidelines when treating cardiovascular disease: a systematic review.

Irish journal of medical science·2025

Same author

Factors influencing patients to choose one obesity treatment over another: a qualitative study.

International journal of obesity (2005)·2025

Same author

Semaglutide and blood pressure: an individual patient data meta-analysis.

European heart journal·2024

Same author

Exploring the readiness of the Irish healthcare system to adopt advanced therapies: a scoping review protocol.

Regenerative medicine·2024

Same author

Risk Factors and Modifiers for Cardiovascular Disease Assessment of Patients with Heterozygous Familial Hypercholesterolaemia.

Journal of clinical medicine·2024

Search research articles

Related Experiment Video

Updated: Jun 18, 2025

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

Statin intolerance and the drucebo effect.

B Mugawar¹, S Mcerlean², P O' Connor^1,3

¹Department of Pharmacology, Trinity College Dublin School of Medicine, Trinity Centre for Health Sciences, St James's Hospital, Dublin, Ireland.

QJM : Monthly Journal of the Association of Physicians

|July 27, 2024

Summary

Statin intolerance, including statin-associated muscle symptoms, increases cardiovascular risk. Educating patients on the negative drucebo effect and statin benefits can improve adherence and reduce risks.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Related Experiment Videos

Last Updated: Jun 18, 2025

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Area of Science:

Cardiology
Pharmacology
Patient Adherence

Background:

Hypercholesterolemia is a significant risk factor for atherosclerotic cardiovascular disease.
Statins are the primary treatment for hypercholesterolemia.
Statin intolerance (SI), especially statin-associated muscle symptoms (SAMS), leads to treatment discontinuation and elevated cardiovascular risk.

Purpose of the Study:

To discuss the challenges of statin intolerance (SI).
To explore the role of the negative drucebo effect in SAMS.
To propose interventions for managing SI and improving statin adherence.

Main Methods:

This commentary reviews existing literature on statin intolerance and the negative drucebo effect.
It synthesizes information regarding patient education and adherence strategies.
It discusses potential interventions to mitigate SI.

Main Results:

A notable portion of SAMS may stem from the negative drucebo effect, influenced by patient expectations.
Patient education on SI and the negative drucebo effect is crucial.
Proactive management strategies can potentially improve statin adherence.

Conclusions:

Addressing patient expectations and the negative drucebo effect is vital for managing SI.
Effective patient education at the initiation of statin therapy can enhance adherence.
Interventions targeting SI can mitigate cardiovascular risk associated with statin non-adherence.